Nanochon is a biotech and medical device company focused on developing innovative orthopedic solutions. Chondrograft™ is a minimally-invasive implant that allows for immediate weight-bearing and motion - meaning less time spent recovering. Nanochon has the potential to deliver more successful and longer-lasting recovery for patients than current standard of care. Our mission is to develop a new approach to treat cartilage replacement and repair so that the hundreds of thousands of young, active patients with joint damage can return to their lifestyles without having to undergo costly and invasive short-term fixes.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/06/24 | $4,000,000 | Seed |
Alumni Ventures Group cultivate(MD) Capital Funds Mountain State Capital University of Virginia Licensing & Ventures Group  | undisclosed |
